Mise en page 1 - Spitta · 4 CENTRAL ORGANIZING COMMITTEE Andrew Colin (Miami, USA) President Eitan Kerem (Jerusalem, Israel) Past President Gary Wong (Hong-Kong, China) Co-Chair,

SCIENTIFIC PROGRAM

www.cipp-meeting.org

CIPPXI-240512_Mise en page 1 30/05/12 16:12 Page1


3

CONGRESS SECRETARIAT

CME CREDITS

Anne F. Bidart, MD

CIPP X Secretariat

27, rue Masséna 06000 Nice, Francee-mail: [email protected]: + 33 (0) 497 038 597Fax: + 33 (0) 497 038 598

CIPP XI - Eleventh International Congress on PediatricPulmonology held in Bangkok, Thailand, from June 30 to July 2, 2012Was granted 18 European CME credits (ECMEC)By the European Accreditation Council for CountinuingMedical Education (EACCME)ECMEC's are recognized by the American MedicalAssociation towards the Physician's Recognition Award (PRA).To convert ECMEC's credit to AMA PRA category I credit,please contact the AMA.

www.cipp-meeting.org

Centara Grand & Bangkok Convention Centre at Central World

999/99 Rama1 Road, Pathumwan, Bangkok 10330

T +66 12 100 1234

CONVENTION CENTER


4

CENTRAL ORGANIZING COMMITTEE Andrew Colin (Miami, USA) PresidentEitan Kerem (Jerusalem, Israel) Past PresidentGary Wong (Hong-Kong, China) Co-Chair, Scientific Program CommitteeHeather Zar (Cape Town, South Africa) Co-Chair, Scientific Program CommitteePetr Pohunek (Prague, Czech Republic) Chair, Abstract and Award CommitteeAndrew Bush (London, UK) Former PresidentBruce Rubin (Richmond, USA) Former PresidentJean-Paul Praud (Sherbrooke, Canada) Former PresidentAnne F. Bidart (France) Executive Secretary

LOCAL ORGANIZING COMMITTEEAroonwan Preutthipan (Bangkok, Thailand) President, Thai CommitteeNuanchan PrapphalTeerachai ChantarojanasiriJitladda DeerojanawongSorasak Lochindarat

Algeria: Rachida Boukari

Argentina: Alejandro Teper

Australia: Peter Le Souef

Austria: Thomas Frischer

Bahamas: Patrick Roberts

Belgium: Christiane De Boeck

Brazil: Renato Stein

Canada: Larry Lands

Chile: Hector Aranibar

China: Yong-Hong Yang

Colombia: Carlos Jimenez Espinel

Cyprus: Panayotis Yiallouros

Czech Republic: Petr Pohunek

Denmark: Frederik Buchvald

Egypt: Samiha Samuel Doss

England: Adnan Custovic

Finland: Matti Korppi

France: Michael Fayon

Germany: Theodor Zimmermann

Greece: Eva Mantzouranis

Guatemala: Edgar Belteton de Leon

Hong Kong: Gary Wong

India: Varinder Singh

Indonesia: Cissy Kartasasmita

Ireland (Northern): Michael Shields

Ireland (Southern): Dubhfeasa Slattery

Israel: Asher Tal

Italy: Giovanni Rossi

Ivory Coast : Flore Amon-Tanoh Dick

Japan: Masato Takase

Kuwait: Abdullah Owayed

Latvia: Ieva Cirule

Lebanon: Paul-Henri Torbey, Zeinat Hijazi

Lituania: Arunas Valiulis

Malaysia: Jessie de Bruyne

Mexico: Laura Gochicoa

Morocco: Amine El Hassani

New Zealand: Catherine Byrnes

Norway: Kai Hâkon Carlsen

Panama: Claude Vergès de Lopez

Peru: Carlos José Mendoza Fox

Philippines: Alexander Tuazon

Poland: Grzegorz Lis

Portugal: Teresa Bandeira

Qatar: Ibrahim Janahi

Romania: Laura Dracea

Russia: Yuri Mitzernitski

Saudi Arabia: Maha Al Dabbagh

Senegal: Mamadou Ba

Serbia: Predrag Minic

Singapore: Anne Goh

Slovak Republic: Martin Brezina,

Jaroslava Orosova

South Africa: Heather Zar

South Korea: Young Yull Koh

Spain: Luis Garcia Marcos,

Antonio Martinez Gimeno

Sweden: Göran Wennergren

Switzerland: Nicolas Regamey

Taiwan: Tsu Fuh Yeh, Frank Lu

Thailand: Aroonwan Preutthipan

The Netherlands: Elianne Vrijlandt

Tunisia: Agnès Hamzaoui

Turkey: Ayhan Goçmen, Nural Kiper

Uruguay: Maria Julia Sarachaga

USA: Judy Voynow, Anastassios

Koumbourlis, Burton Lesnick

Venezuela: Maria Eugenia Garcia Mujica

INTERNATIONAL ADVISORY BOARD


Friends and Colleagues,

It gives me great pleasure to invite you to oureleventh meeting of CIPP - The International

Congress of Pediatric Pulmonology. After almost two decades of activitywe venture to Asia for the first time.

The historic and cultural richness and diversity of this continent makesthe choice of the optimal city challenging. We chose Thailand because ofits natural beauty, invaluable art treasures, its mix of old and modern,and its tradition of excellence in Pediatric Pulmonology.

Our meeting - CIPP - remains the only global meeting that is fully dedicatedto pediatric pulmonology. Over the last two years we changed ourmeeting to an annual paradigm, and saved no effort in our congresses inVienna and Versailles to not only bring together leading authorities onvarious topics, but also make the meeting more inclusive by inviting andsupporting presenters and speakers from poor-resourced countries. Theseresearchers and clinicians are challenged by inadequate funds but arerich in skill and experience, and shared with us the many amazing thingsthat they do. Obviously, the move of the meeting to Bangkok, will giveus an opportunity to include more of our colleagues from Asia andOceania as speakers and presenters, and with that alter the flavor of themeetings to make them even more inclusive.

We are particularly proud of the platform we offer through our YoungInvestigator Awards. For years and consistently these have been excitingpresentations of young researchers on the cutting edge of clinical andbasic science, whose work has been filling plenary sessions and the bestof them are awarded generous prizes.

Despite its growth and global reach, CIPP remains small enough to offerintimacy. It has transformed from its role as a place of learning andscientific exchange, to one that also offers a venue to revive oldfriendships and establish new ones. As we branch out to a new continent,such encounters will broaden horizons, build cross-cultural bridges, andcontribute to unite us all as a better, more educated and open, wiserglobal community.

I with my colleagues in the various committees of the organizationwelcome you to Bangkok and wish you an enjoyable and productivemeeting.

Andrew Colin, MDPresident, CIPP XI

5


6

WELCOME MESSAGE FROM THAILAND

On behalf of the Thai Association of Pediatric Respiratory & Critical CareMedicine (TPRC), we are honored to welcome the renowned speakersand delegates to the 11th International Congress on PediatricPulmonology (CIPP) which will be held in Bangkok, Thailand during June30 to July 2, 2012 at Bangkok Convention Centre at Central World.

This congress is the only international meeting which focused on pediatricpulmonology in the world and this is the first time that the congressmoves to the Asia continent. The fantastic scientific program will coverthe update knowledge on pediatric respiratory diseases includingasthma, infection, sleep disordered breathing, chronic lungs, aspirationand environment related disorders as well as pediatric bronchoscopy,respiratory care and lung function test. It will be an exceptional opportunityto attend our young generation of pediatric pulmonologists to presenttheir research works for the future of our specialty and 4 of them will winthe prestigious CIPP young investigator awards. In addition, there will bespecial awards for the top 3 posters. The congress will also provide a platformfor delegates to participate in radiology quiz, bronchoscopy quiz andinteresting case discussion.

Thailand, in the heart of Southeast Asia, has never been colonized andthus can keep her unique culture and heritage intact. Bangkok has manyattractions to offer. The city is dotted with 400 glittering Buddhist templesof great beauty, magnificent palaces, classical dance performances,numerous shopping centers. Bangkok features a modern capital city, andfriendly people who epitomize Thailand’s “land of smiles” reputation.The Bangkok Convention Centre at Central World, the congress venue, issituated in the heart of Bangkok where delegates can walk around safelyeven late at night. It is the gateway to Bangkok’s most-happeningshopping, dining and entertainment scene. More importantly, it is closedto the BTS modern skytrain station so everyone could explore mostattractive parts of our beautiful city without any delay in traffic jams.

We together with our Thai colleagues of TPRC would like to thankProfessor Andrew Colin, the President of CIPP XI and international CIPPorganizing committee for selecting Bangkok as the venue and all sponsorsfor supporting generously to the congress. We assure that all delegateswill have memorable experiences and wonderful hospitality.

Yours sincerely,

Nuanchan Prapphal, MD

President of Thai Association of Pediatric

Respiratory & Critical Care Medicine (TPRC)

Aroonwan Preutthipan, MD, FCCP

Scientific Chair of TPRC

President, Local Organizing Committee

of CIPP XI


04:30 pm - 05:30 pm

OPENING CEREMONYWelcoming Addresses & Keynote Speaker

Room A

08:30 am - 10:00 am

PLENARY SESSIONInvited Speaker & Young Investigator's Presentations

Room Ap.13

10:00 am - 10:30 am

COFFEE BREAK & EXHIBITION VISIT

Exhibition Hall

OBSTRUCTIVE LUNG DISEASES

Asthma Update

10:30 am - 12:00 pmRoom A

p.14

INFECTION, INFLAMMATION& OTHER TOPICS

Lung Infections inChildren

10:30 am - 12:00 pmRoom B

p.14

PEARLS

Home Ventilation

10:30 am - 12:00 pmRoom C

p.14


Environment andRespiratory Diseases

in Children

03:00 pm - 04:30 pmRoom A

p.17


Neonatal Disorders

03:00pm - 04:30 pmRoom B

p.17

PEARLS

Bronchoscopy

03:00 pm - 04:30 pmRoom C

p.17

01:30 pm - 03:00 pm


Room A

p.16

PFIZER Satellite SymposiumThe Forgotten Killer in Children: What Can We Do?

Room A

08:00 pm - 11:00 pm

Faculty & International Advisory Board Working Dinner

To be announced later

05:30 pm - 07:00 pm

Welcoming Cocktail

Exhibition Hall

p.18p.18

12:00 pm - 01:30 pm

7Saturday June 30, 2012p.15


INTERACTIVE POSTER SESSION

01:30 pm - 03:00 pmPoster Area

p.24

WORKSHOPPediatrics is Magical

01:30 pm - 03:00 pmRoom C

p.32

08:00 pm - 12:59 am

GALA DINNER & YOUNG INVESTIGATOR AWARD CEREMONY

p.35

To be announced later


Acute Severe Asthma

10:30 am - 12:00 pmRoom A

p.22


Chronic Lung Conditions

10:30 am - 12:00 pmRoom B

p.22

PEARLS

Sleep and OSAS

10:30 am - 12:00 pmRoom C

p.22


Asthma Monitoring

05:00 pm - 06:30 pmRoom A

p.34


Tuberculosis in Children

05:00pm - 06:30 pmRoom B

p.34

PEARLS

Lung Disease and Lung Function

05:00 pm - 06:30 pmRoom C

p.34

12:00 pm - 01:30 pm

Room A

08:30 am - 10:00 am


Room Ap.21

03:00 pm - 04:30 pm


Room A

p.33

10:00 am - 10:30 am

Exhibition Hall

04:30 pm - 05:00 pm


Exhibition Hall

p.23MSD Satellite SymposiumUnderstanding the Challenges of One Air Way Diseases


8 Sunday July 01, 2012


04:30 pm - 05:00 pm

CLOSING CEREMONY

p.43

Room A

10:00 am - 10:30 am

COFFEE BREAK & EXHIBITION VISITExhibition Hall


Lung and AirwayInflammation

10:30 am - 12:00 pmRoom A

p.40


Effusion and Empyema

10:30 am - 12:00 pmRoom B

p.40

PEARLS

New and Hot Topics inRespiratory Care

10:30 am - 12:00 pmRoom C

p.40

CLINICAL RADIOLOGICAL QUIZDENOUEMENT

01:30 pm - 03:00 pmRoom A p.42

CLINICAL CASE PRESENTATIONS

01:30 pm - 03:00 pmRoom B

p.42

BRONCHOSCOPY QUIZ DENOUEMENT

03:00 pm - 04:30 pmRoom A

p.42

08:30 am - 10:00 am

PLENARY SESSION2011 THE YEAR IN REVIEW

Room Ap.39

05:00 pm - 05:30 pm

FAREWELL COCKTAIL

Paediatric Respiratory Reviews (Elsevier) Satellite SymposiumConverting Research into Publications

Room A

12:00 pm - 01:30 pm

9Monday July 02, 2012

p.41


PUBLICITE


SaturdayJune 30, 2012



Chairmen: Gary Wong (Hong Kong, China)Petr Pohunek (Prague, Czech Republic)

08:30 am - 09:00 am : invited speakerAndrew Colin (Miami, USA)Fetal Bronchoscopy and its Possible Role in Altering the Natural History of Congenital Malformations of the Lung.

09:00 am - 10:00 amYoung Investigator's Oral Presentations.

1. The Effect of Different Dosage of Vitamin D Supplementation in Early Life on the Expression of Vitamin D Receptor (VDR) on the Lung in Rat with Asthma.Ling-Yan Chen (Shanghai, China)

2. GWAS Replication Identifies PROC To Be a Novel Candidate Gene for Childhood Asthma.Wa Cheong Chan (HongKong, China)

3. Asthma Control and Quality of Life in School Aged Children in Enugu South East Nigeria.Adaeze Ayuk (Enugu, Nigeria)

PLENARY SESSIONInvited Speaker & Young Investigator's Presentations08:30 am - 10:00 am Room A

Saturday June 30, 2012 13


OBSTRUCTIVE LUNG DISEASESAsthma Update

Chairpersons: Jessie de Bruyne (Kuala Lumpur, Malaysia)Annabelle Quizon (Miami, USA)

1. Asthma Treatment: From Steroids to Cytokines and Chemokines Blockers and Beyond.Fernando Martinez (Tucson, USA)

2. Assessment and Management of Exercise-induced Asthma.Larry Lands (Montreal, Canada)

3. Effective Delivery of Medications to Your Asthmatic Patients. Sunalene Devadason (Perth, Australia)

PEARLSHome Ventilation

Chairpersons: Kun-Ling Shen (Beijing, China)Jean-Paul Praud (Sherbrooke, Canada)

1. Institutional and Home Management of Respiratory Failure - Exploring the Range of Monitoring from ICU to Home.Virginia Sison Kharasch (Boston, USA)

2. Approach To Establishment of Home Ventilation in Resource Limited Environment.Aroonwan Preutthipan (Bangkok, Thailand)

3. PSG for Titration of Home Ventilation. Narong Simakajorboon (Cincinnati, USA))

10:30 am - 12:00 pm Room A

10:30 am - 12:00 pm Room C

14 Saturday June 30, 2012

INFECTION, INFLAMMATION & OTHER TOPICSLung Infections in Children

Chairpersons: Cissy Kartasasmita (Jakarta, Indonesia)Matti Korppi (Kuopio, Finland)

1. Lung Abscess in Children: Management and Outcome. Dominic Fitzgerald (Sydney, Australia)

2. Antibiotic Resistance of Pneumococcus.Yong-Hong Yang (Beijing, China)

3. Treatment Controversy in Childhood Pneumonia.Eitan Kerem (Jerusalem, Israel)

10:30 am - 12:00 pm Room B



Chairman: Teerachai Chantarojanasiri

1. Influenza and Univited Colleges: How Can We Manage?Somsak Lolekha (Thailand)

2. CAP: Optimized Treatment for the Best Outcome.Veerachai Wattanaveradej (Thailand)

PFIZER Satellite SymposiumThe Forgotten Killer in Children: What Can We Do?12:00 pm - 01:30 pm Room A


16 Saturday June 30, 2012

Chairpersons: Heather Zar (Cape Town, South Africa)Petr Pohunek (Prague, Czech Republic)

01:30 pm - 02:00 pm: PM Invited Speaker

Giovanni Rossi (Genoa, Italy)Reflux and Pulmonary Disease in Childhood.

02:00 pm - 03:00 pm Young Investigator's Oral Presentations

1. A Single Dose of Azithromycin Has No Clinical Efficacy in Children Aged < 18 Months Hospitalized with Acute Bronchiolitis: A Double-blinded, Randomized, Placebo-controlled Trial.Gabrielle McCallum (Darwin, Australia)

2. Correlation of Tuberculin Skin Test Result with Severity of Tuberculosis in Children 0-5 Year Old.Fanny Gae Sermise-Gadian (Manila, Philippines)

3. BCV May Be Set to One of the Treatments of Asthma Exacerbation in Children.Yutaka Ueda (kumagaya, Japan)

PLENARY SESSIONInvited Speaker & Young Investigator's Presentations01:30 pm - 03:00 pm Room A


OBSTRUCTIVE LUNG DISEASESEnvironment and Respiratory Diseases in Children

Chairpersons: Jessie de Bruyne (Kuala Lumpur, Malaysia)Teerachai Chantarojanasiri (Bangkok, Thailand)

1. Smoking and Lung Health in Children.Narong Simakajornboon (Cincinnati, USA)

2. Pollution and Its Impacts on Respiratory Outcomes in Children from Developing Countries.Alexander Tuazon (Manila, Philippines)

3. Premature Infants: The Impact of Environmental Stimuli on Lung Development in Early Life. Renato Stein (Porto Alegre, Brazil)

INFECTION, INFLAMMATION & OTHER TOPICSNeonatal Disorders

Chairpersons: Zeinat Hijazi (Beirut, Lebanon)Zen-Kong Dai (Kaohsiung, Taiwan)

1. Prevention of BPD in 2012.Tsu Fuh Yeh (Taipei, Taiwan)

2. Apnea of Prematurity and Beyond.Jean-Paul Praud (Sherbrooke, Canada)

3. Non-invasive Ventilation Strategy in Newborns. Amir Kugelman (Haifa, Israel)

PEARLSBronchoscopy

Chairpersons: Hajnalka Szabo (Budapest, Hungary)Frank Lu (Taipei, Taiwan)

1. Pro/Con Debate: Airway Stenting Is an Important and Underutilized Intervention in Pediatric Bronchial Diseases.PRO: Wen-Jue Soong (Taipei, Taiwan)CON: Robert Wood (Cincinnati, USA)

2. Removal of Foreign Body by Flexibble Bronchoscopy. Petr Pohunek (Prague, Czech Republic)

03:00 pm - 04:30 pm Room A

03:00 pm - 04:30 pm Room B

03:00 pm - 04:30 pm Room C



18 Saturday June 30,2012

OPENING CEREMONYWelcoming Addresses & Keynote Speaker04:30 pm - 05:30 pm Room A

Welcoming Addresses:Andrew Colin, President CIPP XIGary Wong, Chair Scientific Program CommitteeAroonwan Preutthipan, President Local Committee

Keynote Speaker: Peter LeSouef (Perth, Australia)The Early Origins of Childhood Asthma: Allergens,Infections and Genes.

CLOSING CEREMONY

08:00 pm - 11:00 pm To be announced later

Faculty & International Advisory Board Working Dinner


SundayJuly 01, 2012



Chairmen: Bruce Rubin (Richmond, USA)Petr Pohunek (Prague, Czech Republic)

08:30 am - 09:00 am: Invited Speaker

Gary Wong (Hong Kong, China)What Have We Learnt from Asthma Epidemiology Studies?

09:00 am - 10:00 am Young Investigator's Oral Presentations

1. Parameters of Noninvasive Ventilation (NIV) Success in Pediatric Impending Respiratory Failure. Chonnibha Marukatat (Bangkok, Thailand)

2. The Effect of Substance P on Asthmatic Rat Airway Smooth Muscle Cell Proliferation, Migration and Cytoplasmic Calcium Concentration in vitro.Miao Li (Shenyang, China)

3. Predictors of Postoperative Pulmonary Complications in Children Undergoing Cardiothoracic Surgery. Maria Niña Banque (Quezon City, Philippines)

PLENARY SESSIONInvited Speaker & Young Investigator's Presentations08:30 am - 10:00 am Room A

Sunday July 01, 2012 21


OBSTRUCTIVE LUNG DISEASESAcute Severe Asthma

Chairpersons: Göran Wennergren (Gothenburg, Sweden)Varinder Singh (New Delhi, India)

1. Management of Life-threatening Asthma.Bruce Rubin (Richmond, USA)

2. Role of Viral Infections in Asthma Exacerbations.Peter LeSouef (Perth, Australia)

3. Anticholinergics in the Treatment of Childhood Asthma. Giovanni Rossi (Genoa, Italy)

INFECTION, INFLAMMATION & OTHER TOPICSChronic Lung Conditions

Chairpersons: Dominic Fitzgerald (Sydney, Australia)Laura Gochicoa (Mexico, Mexico)

1. Update on Primary Ciliary Dyskinesia.Hartmut Grasemann (Toronto, Canada)

2. Modern Management of Cystic Fibrosis. Eitan Kerem (Jerusalem, Israel)

3. Chronic Lung Disease in HIV Infected Children. Heather Zar (Cape Town, South Africa)

PEARLSSleep and OSAS

Chairpersons: Daniel Ng (Hong Kong, China)Carlos José Mendoza Fox (Lima, Peru)

1. Sleep Disordered Breathing: Lessons from Animal Models.Jean-Paul Praud (Sherbrooke, Canada)

2. PSG and Other Modalities to Diagnose OSAS.Narong Simakajorboon (Cicinnati, USA)

3. Long-term outcome of Childhood OSAS.Albert Li (Hong Kong, China)

10:30 am - 12:00 pm Room A

10:30 am - 12:00 pm Room B

10:30 am - 12:00 pm Room C



MSD Satellite SymposiumUnderstanding the Challenges of One Air Way Diseases

12:00 pm - 01:30 pm Room A


Chairman:

1. Exploring Role of Phenotype in the Management of Pediatric Asthma.Gary Wong (Hong Kong, China)

2. Strategic Management of Upper Airway Diseases.Pantipa Chatchatee (Thailand)


INTERACTIVE POSTER SESSION

01:30 pm - 03:00 pm Poster Area

Category 1. Bronchial asthma and other chronic obstructivepulmonary diseases.

A1-15 – Comparison of the results of pulmonary function test between the bronchial asthma infants and the infants with bronchiolitis obliterans.Li Xiang, Xiaochun Rao, Anxia Jiao

A2-49 – The Effect of Different Dosage of Vitamin D Supplementation in Early Life on the Expression of TGF-α1 and Smad3 in the Lung of Rat with Asthma.C Chen, XJ Zhou, X LI, Z LI, JG Hong

A3-53 – Methacholine Challenge Tests Results in Children are Season Dependent.LJ Joseph, E Picard, B Dayan, S Goldberg

A4-56 – Title: Do Aeroallergen Sensitization and Immunoglobulin E Levels Correlate with Severity of Asthma in Malaysian Children.KP Eg, A.M. Nathan, J deBruyne, F. Khalid

A5-67 – Effect of Caesarean Section on Wheezing Disorders.Ya-Nan Li, Huan-ji cheng, Li liu,Hong-mei qiao

A6-71 – Clostridium Leptum-Induced Regulatory T Cells Protect Against Asthma.Ya-Nan Li, Huan-ji Cheng

A7-81 – Health-Related Quality of Life in School-Aged Children with Asthma in Enugu, South East Nigeria.A Ayuk, T Oguonu, BC Ibe, AN IkefunaKEFUNA

A8-102 – Involvement of the Respiratory and Ocular Systems in X-linked Hypohidrotic Ectodermal Dysplasia.T.J.H. Zimmermann, J. Dietz, T. Kaercher, A-T Schneider, Kenneth Huttner, R. Johnson, H. Schneider

A9-106 – Pathology and Airway Reactivity Changes in Galectin-7 Transgenic Mice.Shunying Zhao, Ruxuan He

A10-109 – Crude Extract of Black Seed (Nigella sativa) can Modulate T CD4+CD25+FoxP3+ Lymphocytes in Asthmatic Mouse Model.W Barlianto, HMS Chandra Kusuma, M Aris Widodo, Setyawati Suharto

A11-134 – Human Rhinovirus is Highly Prevalent in Hong KongChildren with Wheezing Illnesses.TF Leung, LY Tse, WY Lam, WC Chan, GWK Wong, PKS Chan

A12-148 – The Role of ADMA, SDMA, Arginine and NO in Pediatric Bronchial Asthma.NP Consilvio, M Verini, G Riccioni, V Bucciarelli, E Di Ilio,A Pennelli, L Scotti, S Di Pillo, A Scaparrotta, F Chiarelli



A13-226 – Spirometric Airflow Obstruction in Asymptomatic Bangkok School Children: Prevalence and Risk Factors.A Preutthipan, S Suwanpromma, C Boonlarbtaweechoke,U Udomsapayakul

A14-233 – Silencing IL-25 Expression by RNA Interference in Asthma Mouse.Huanji Cheng, Li Liu, Hong Guo, Hongmei Qiao, Jianing Yin, Xiuhua Yu, Jirong Lu

A15-258 – Is there any Association between Croup in Childhood and Abnormalities of Pulmonary Function test in Adolescent?M Modaresi, Jamal Faghihinia, Ali Pourvali

A16-262 – The Prevalence of Atopic Asthma in Children Ages 6-7 Years in Padang city and Associated Risk Factors.F Fitry Yani, D Hayati, R Rusdi

A17-267 – Human Rhinovirus Infection in Children with Lower Respiratory Tract Infection and Asthmatic Children in Southern Taiwan.Y Su, Ching-Chi Yang, Ya-Ling Huang

Category 2. Allergic Bronchopulmonary Disorders (excluding bronchial asthma)

B1-80 – Hypereosinophilic Syndrome Presenting with Pleural Effusion in Children: A Case report.Huangji Cheng, Hailong You, Yunfeng Zhang, Qingran Yang, Ye Liu

Category 3. Bronchopulmonary and Pleural Infections(including tuberculosis)

C1-20 – The Effectiveness of Magnesium Sulfate Nebulizer in Treatment of Acute Bronchiolitis.Mohammadreza Modaresi, Jamal Faghihinia, Hosein Mirlohi, Farhad Pjang

C2- 50 – RSV Mortality in Singapore.A Goh, H Hajirah

C3-54 – Life Threatening Complications of Necrotizing Pneumonia: a Report of Two Cases.N Demirel, Annabelle quizon , Edgar Beltetón, Joel reiter, Andrew colin

C4-64 – A Complicated case of Pneumococcal Pneumonia and Empyema in a Girl of 2 year old.S.G. Mosescu, C.M. Zapucioiu

C5-68 – Complicated Pneumococcal Pneumonia in Children at an University Hospital in São Paulo (Brazil).C Ryoka Miyao Yoshioka, Alfredo Elias Gilio, Selma Betta Ragazzi, Maria Cristina de Cunto Brandileone,João Paulo Becker, Marina Buarque Martinez, MariaLuiza Guerra, Silvia Santos



C6-79 – Clinical Severity and iPFT Compare Between Subgroups of Respiratory Syncytial Virus in ChildrenHospitalized with Acute lower Respiratory Tract Infection.T Trisorus, R Samransamraujkit, J Deerojanawong, S Sritippayawan, N Prapphal

C7-105 – Combined Treatment of Macrolide Antibiotics with Glucocorticoid or Intravenous Immunoglobulin in Children Mycoplasma Pneumoniae Lobar Pneumonia.L Shan, Zhijia wang, Ning chen, Xuxu Cai, Xiaohua Han, Linhua Shu, Yunxiao Shang

C8-162 – Risk Factors of Pneumonia in Measles Children at Dr Soetomo Hospital Surabaya.Retno Asih Setyoningrum, Kusdwijono Kusdwijono, Deddy Iskandar, Landia Setiawati, Ismoedijanto Ismoedijanto

C9-172 – Lower Respiratory Tract Infection from Human Metapneumovirus in Hospitalized patients between2 months- 5 Years of Age in Thailand.Sorasak Lochindarat, Kazunori Oishi, Kazuyoshi Kawakami, Roongrawee Torbunsupachai

C10-187 – Disseminated Tuberculosis Involved in Pulmonary, Bronchus, Abdominal Cavity, Intracalvarium and Spinal column: A Case Report and Review of the Literature.H Wang, BP Xu

C11-205 – Immune Reconstitution Syndrome (IRIS) in a Child with Disseminated Tuberculosis.I D Ba, G Lapierre, D Bérubé, M F Buteau, J E Marcotte,S Jacob, M Ba, P M Faye

C12-230 – Clinical Significance of IL-5 and VEGF in BALF with Mycoplasma Pneumoniae pneumonia.Huanji Cheng, Hongmei Qiao, Li Liu, Hao Sun, Jirong Lu, Junzhao Lii

C13-231 – The Effect of TNF-α, IL-12 and CysLTs on the Pathogenesis of MPP in Children.Huanji Cheng, Jianing Yin, Li Liu, Hongmei Qiao, Jirong Lu

C14-235 – Ethambutol in Children with Tuberculosis- How safe is it?G R Sethi, Vipin Khandelwal, J L Goyal, Dhulika Dhingra, V Singh, A Khanna, M Mantan

C15-251 – Acute Lower Respiratory Tract Infection and Vitamin D status in Children.A T Aslan, T Eyuboglu, O Gulbahar, S Ozkan



Category 4. Noninfectious Respiratory Disorders

D1-36 – Ambulatory Blood Pressure monitoring in Chinese Children with Snoring and Obstructive Sleep Apnea/Hypopnea Syndrome.Z Xu, Bei Li, Kunling Shen

D2-65 – Impact of Adenotonsillectomy on the Immune Function of SDB Children Younger than 7 Years.T Sugiyama, K Saito, K Sugita

D3-145 – Predictors of Changes in Snoring in children from 5 to 8.5 years: Findings from the Prospective CohortStudy of Thai Children.Wanaporn Anuntaseree, Pasuree Sangsupawanich, Ladda Mo-suwan, Nannapat Pruphetkaew

D4-146 – Congenital Tracheal Stenosis in A Baby.Deddy Iskandar, Rahman Mahrus, Retno Asih Setyoningrum, Landia Setiawati

D5-177 – Case Report of Right Lung Agenesis: Is There a Rolefor the Use of CPAP?S C Su, A Rus Anida

D6-264 – Diaphragmatic Eventration Complicated by Diaphragmatic Herniation: When is plication indicated?N Demirel, J Reiter, A Quizon

Category 5. Fetal and Neonatal Respiratory Disorders

E1-52 – Severe Unique Age-Specific Secondary Pulmonary Arterial Hypertension in Infancy.Zen-Kong Dai, Jiunn-Ren Wu, I-Cheng Chen

E2-161 – Neonatal Outcome of Two Pregnant Women with Multidrug-Resistant Tuberculosis.Landia Setiawati, Retno Asih Setyoningrum, Nazara Agustina, Deddy Iskandar, Martono Tri Utomo, Risa Etika

Category 6. Cystic Fibrosis

G1-188 – Nasossinusal Evaluation of Cystic Fibrosis Patients.MOC Fatuch, N Rosario, A Carvalho, R Pereira

G2-249 – Newborn Screening for Cystic Fibrosis Leads to Diagnosis in Older Siblings of Diagnosed Newborns.T. Kucerova, V. Skalicka, J. Bartosova, A. Holubova, V. Vavrova, A. Holcikova, P. Pohunek

Category 7. Respiratory Manifestations of Extra-PulmonaryDiseases (including AIDS)

H1-160 – Tourette’s Syndrome Manifest as Chronic Cough in Children.MT Wang, Jiaan-Der Wang, Sho-Fen Lee



H2-163 – Association of Airway Nitric Oxide Levels with Phenotypic Charecteristics in Children with Sickle Cell Disease.GN Bendiak, D Mateos-Corral, A Sallam, H Grasemann

H3-179 – Exhaled Nitric Oxide as a Measure of Pulmonary Involvement in the Inflammatory Process in Children with Crhon's Disease. G Gut, A Lahav, A Ben Tov, R Soferman, S Cohen, M Farber, S Reif, Y Sivan

H4-238 – Mediastinal Mass Mimicking Allergic Asthma.L Jankauskaite, Dr. Miseviciene V., Dr. Kiudeliene R, Prof. Kevalas R, Dr. Poskiene L

H5-239 – Recurrent Apnea Episodes as an Onset of a Primary Pulmonary Hypertension, a Case Report.L Jankauskaite, Dr. Miseviciene, Prof. Kevalas R

Category 9. Epidemiology, Environmental Risks, Prevention,Socio-economic Cost, Public Health Resources

J-141 – Assessment of Tobacco Smoke Exposure in Hong KongPreschool Children: Questionnaire or Urinary Cotinine?TF Leung, IHS Chan, TC Liu, WC Chan, HY Sy, GWK Wong, CWK Lam

J2-58 – Indoor and Outdoor Risk Factors Related to AllergicRhinitis and/or Asthma in Children and Adolescents.P A. M. Camargos, S Azalim, AL Alves

J3-184 – Quantitative Comparation of Mice Alveolar Macrophage Due To Acute and Subacute Inflammation by Coal Dust Exposure.HMS Chandra Kusuma, Nia Kania, Soesandy Oetama, W Barlianto, Ery Olivianto

J4-222 – Respiratory health survey in children from a rural community in México. L Rodríguez-Moreno, L Torre-Bouscoulet, Rogelio Pérez-Padilla, MR Fernández-Plata, D Martínez-Briseño, L Gochicoa-Rangel

J5-259 – Burden of Influenza in Children in the Community. C B. Kartasasmita, C Murad, K Mutyara, P Tessa

Category 10. Investigation and Diagnostic Tests

K1-74 – Respiratory Mechanics in Healthy Newborns Studied with the Forced Oscillation Technique. H Szabo, Z Gyurkovits, B Radics, B Maár, H Orvos, P D Sly, Z Hantos

K2-76 – The Contribution of Computerized Tomography to the Diagnosis and Treatment of Tracho- and Broncho-Malacia in Children.S Cohen, Beni Kupelevtz, Avraham Avital, Chaim Springer



K3-117 – Impact of the Use of Rapid Antigen DetectionTest in the Diagnosis and Treatment of Acute Pharyngitis in Pediatric Emergency Room.JB Lotufo, DM Cardoso, AE Gilio, SH Hsin, BM Machado, M de Paulis, MB Martinez, SJE Grisi

K4-142 – Reference Standards for Forced Expiratory Parameters Measured by Incentive Spirometry in Chinese Preschool Children.TF Leung, KK Mak, TC Liu, XF Su, HY Sy, WC Chan, AM Li, GWK Wong, S Lum

K5-180 – Comparison of Borg & Dalhousie Pictorial Scales Measuring Perceived Exertion During Exercise in Children.PT Pianosi, M Huebner, Z Zhang, P McGrath

K6-216 – Flexible Bronchoscopy in children: A 13 year Experience from a Tertiary Care Center from North India.V Singh, Ankit Parakh

K7-221 – Diffusing Capacity of the Lung for Carbon Monoxide Test in Children Between 4 and 10 Years Old. A quality control study.Gabriela Cantú-González, Laura Gochicoa-Rangel, Luis Torre-Bouscoulet, Mónica Silva-Cerón, Alejandro Alejandre-García, Rogelio Pérez-Padilla, JC Vázquez-García

K8-261 – Detection Influenza Virus by Rapid Test for Pneumonia in Children: Study in Hospital.DA Wulandari,CB Kartasasmita

K9-266 – Relation of Lower Airway Anomalies in Children With the Diagnosis of Congenital Heart Disease.C Wang, Shyh-Jye Chen, En-Ting Wu, Frank Lu, Mei-Hwan Wu, Jou-Kou Wang

Category 11. Therapeutic Procedures

L1-8 – Obliterative Lower Airway Lesions in Childhood: Bronchoscopic Diagnosis and Clinical Spectrum.AI Quizon, P Minic, P Pohunek, A Tal, AA Colin

L2-100 – Evidence Based Design Of Face Masks For Children Through Computerized 3D Face Analysis.I Amirav, A Luder, A Halamish, R Kimmel, D Raviv, M Newhouse

L3-166 – Nasal Aerosol Delivery to the Lower Respiratory Tract may be Superior to Oral delivery in Infants/Toddlers.I Amirav, A Halamish, M Newhouse

L4-212 – Flexible Bronchoscopic Extraction of Tracheobronchial Foreign Bodies in Children: Lessons Learnt - A 10 year Experience from North India.Varinder Singh, Md Umar Tak, Ilin Kinimi, Soumya Patra, Ankit Parakh



Category 12. Cellular and Molecular Biology

M1-126 – Corticosteroids Inhaled Could Inhibit Substance P Receptor Expression in Asthmatic Rat ASMC.M Li, YX Shang

Category 13. Pediatric Pulmonology in DevelopingCountries

N1-34 – The Quality of Life of a 12-Year- Old Malnourished Girl With Tuberculous Pericarditis.H Ariani

N2-62 – Characteristic of Children Hospitalized with Severe Acute Respiratory Infection in West Nusa Tenggara Hospital Mataram Indonesia.Indriyani Sak, Lokida Dewi

N3-88 – High Infection Rate Of Tuberculosis Infection in Children Exposed to Household Contact of Multidrug Resistant Tuberculosis. E Olivianto, Endah Setyorini, Vivi Ratnasari, Dessy Wulandari, HMS Chandra Kusuma

N4-91 – Massive Pleural Effusion Due to Radiologically Diagnosed Pulmonary Malignancy In A 4-Year old Girl.E Olivianto, Rurin Septiana, HMS Chandra Kusuma

N5-130 – Correlation of Physiologic Functional Variable with Hemodynamic Variables Among Filipino Children with Pulmonary Arterial Hypertension: Philippine Heart Center Experience. K D.Y. Daban, P Mateo, D Requiron-Sy, M Bautista, F Ayuyao, T De guia

N7-168 – Risk Factors for Childhood Pneumonia Associated With Length of Stay at Sanglah Hospital Denpasar Bali.P Siadi Purniti, Ida Bagus Subanada, Ayu Setyorini Mestika Mayangsari

N8-170 – Prevalence of symptoms of Sleep-Related BreathingDisorders in South Indian children.Biju Thomas, Arun Pugalenthi, Dennis James, SS Krishnamoorthy, Cecilia A Chandra, T U Sukumaran

N9-217 – Persistent and Recurrent Pneumonia in Children: A clinico-investigative profile from North India.Ankit Parakh, V Singh, Rajesh Kumar Meena, M K Narula, Praveen Kumar, J Chandra

N10-224 – Efficacy of Nebulized Hypertonic Saline and Albuterol Combination for the Management of Acute Bronchiolitis: a Randomized, Double-Blind Controlled Trial.Subanada Ida Bagus, Siadi Purniti Putu

N11-225– Clinical Features of Community Acquired Pneumonia with Different Hemoglobin Status.Ismiranti Andarini



N12 -227 – Factors Associated with Mortality of Childhood Pneumonia at Sanglah Hospital.Subanada Ida Bagus, Siadi Purniti Putu

N13-248 – Nasopharyngeal Tuberculosis in Children: a case report.W Indawati

N14-250 – Prognostic Factors of Hospitalized Children with Pneumonia.DB Setyanto, CG Ambarsari, N Kaswandani

N15-252 – Symptoms and Signs Related to Confirme Cirological and Serologic Among Children with Influenza-Like Illness in Primary Health Care.F Fitry Yani, C Chaidir, A Aziz Djamal, R Machmoed, D Basir

N16-253 – Prevalence and Risk Factors of Tuberculosis Infection Among Child Contacts of Pulmonary Tuberculosis Cases.R Triasih, S Graham

N17-254 – The Efficacy of Adding Ipratropium Bromide to Salbutamol Nebulization for Mild Acute Asthma Attack in Children.B Supriyatno, M Harumdini, W Indawati

N18-255 – Risk Factors of Tuberculosis in HIV-positive Children.N Kaswandani, N Kurniati

N19-256 – Factors Associated with Severe Tuberculous Disease in Children.Subanada Ida Bagus, Siadi Purniti Putu

N20-263 – Bronchoscopic Assessment of Airway Involvement inChildren Presenting With Clinically Significant Airway Obstruction Due to Tuberculosis.P Goussard, RP Gie, S Kling, S Andronikou, JT Jansen,G Roussouw

Category 14. Miscellaneous

O1-23 – A Prospective Randomized Open Trial of Saline Nasal Irrigation and Decongestant for Sinusitis in Children.H Kim, JS Yoon, JS Lee

O2-28 – The Management of Spontaneous Pneumothorax inChildren – A Review of the Published Literature.I Lepcha,DYT Daniel YT Goh, MBR Mahesh Babu R, EH Eugene Han, GJC Gary J Connett

O3-66 – Profile of Patients in the Anti-Smoking Treatment Group in the UH USP.JB Lotufo, E.T.C Souza, M. H. Fukuoka, A. B. Sousa

O4-72 – Comparison of the Therapeutic Use of Varenicline Versus Nicotine Replacement in the Gat UH-USP.J B Lotufo, S. H. Hsin, A. B. Souza, E.C. Souza, M. H. Fukuoka



O5-73 – Supply of Anti-Smoking Medication X Giving Up and Therapeutic Success at the Anti-Smoking Groupin the HU-USP.J B Lotufo

O6-75 – Evaluation of Urinary Cotinine as a Diagnostic test of Active and Passive Tobacco Smoking.JB Lotufo, S.E. Vieira, A.A. Ferraro, M. Yonamine

O7-99 – Disseminated Cryptococcosis in 28 Previously Healthy Children Baoping XU, Kunling Shen, Shunying Zhao

O8-111 – Comparison of Two Measurement Methods in Vitrofor Metered Dose Inhalers and Valved Holding Chambers. N Boukhettala, P Diot, T Poree, L Vecellio

O9-173 – Compliance to Non-Invasive Home Ventilation in Children With Obstructive Sleep Apnoea in a Tertiary Pediatric Hospital, Singapore. A Marie Nathan, JPL Tang, A. Goh, OH Teoh, OM Chay

O10-197 – Effectiveness and Safety of Continuous Intravenous Furosemide Infusion to Control Fluid Balance in Critically Ill Children with Acute Lung Injury and Ards.Surasit Sakrasae, Dusit Staworn, Sanitra Sirithangkul,Supichaya Chuengchitraks, Chalida Laohapand

O11-218 – Hypoplastic Epiglottis in a Non Syndromic Child: A Rare Cause of Chronic Cough.Ankit Parakh, V Singh

O12-219 – The Progression of Blood Pressure Changes in Children with Mild Sleep-disordered Breathing.JSH Chan, CH Chan, SY Leung, DKK Ng


WORKSHOPPediatrics is Magical01:30 pm - 03:00 pm Room C

Director: Bruce Rubin (Richmond, USA)


Chairmen: Eitan Kerem (Jerusalem, Israel)Petr Pohunek (Prague, Czech Republic)

03:00 pm - 03:30 pm: Invited Speaker

Fernando Martinez (Tucson, USA)The Most Important Asthma Trials Published in the Past Year.

03:30 pm - 04:30 pm Young Investigator's OralPresentations

1.Genotypic, Genetic and Molecular Characteristics of Erythomycin C Resistant Streptococcus Pneumonia from Pediatric Patients in Beijing 2010. Lin Zhou (Beijing, China)

2.Respiratory Viruses Detection Using Multiplex PCR in Children with Severe Community Acquired Pneumonia at Ramathibodi Hospital, Thailand. Tippawan Wannachai (Bangkok, Thailand)

3.Clinical Severity and iPFT Compare between Subgroups of Respiratory Syncytial Virus in Children Hospitalized with Acute Lower Respiratory Tract Infection.Thitiya Trisorus (Bangkok, Thailand)

PLENARY SESSION

03:00 pm - 04:30 pm Room A



OBSTRUCTIVE LUNG DISEASESAsthma Monitoring

Chairpersons: Anne Goh (Singapore, Singapore)Cissy Kartasasmita (Jakarta, Indonesia)

1. Pro/Con Debate: Asthma Should Be Monitored by Exhaled Nitric Oxide (FeNO).PRO: Hartmut Grasemann (Toronto, USA)CON: Daniel Goh (Singapore, Singapore)

2. Biomarkers -Other than FeNO- for Asthma Monitoring.Andrew Bush (London, UK)

INFECTION, INFLAMMATION & OTHER TOPICSTuberculosis in Children

Chairpersons: Aroonwan Preutthipan (Bangkok, Thailand)Alexander Tuazon (Manila, Philippines)

1. Advance in the Diagnosis of Childhood Tuberculosis.Heather Zar (Cape Town, South Africa)

2. Tuberculosis in Developing Countries Varinder Singh (New Delhi, India)

3. Treatment Approach in Childhood Tuberculosis.Tawee Chopitayasunondh (Bangkok, Thailand))

PEARLSLung Disease and Lung Function

Chairpersons: Elianne Vrijlandt (Rotterdam, The Netherlands)Laura Dracea (Brasov, Romania)

1. Nutrition and Lung Diseases in Children.Larry Lands (Montreal, Canada)

2. Pulmonary Aspiration Syndrome - Diagnostic and Treatment Challenges?Ibrahim Janahi (Doha, Qatar)

3. Advances in Infant and Preschool Lung Function Testing.Sarath Ranganathan (Melbourne, Australia)

05:00 pm - 06:30 pm Room A

05:00 pm - 06:30 pm Room B

05:00 pm - 06:30 pm Room C



YOUNG INVESTIGATOR’S AWARD CEREMONY08:00 pm - 12:59 am To be announced later

• Gala Dinner & Young Investigator Award Ceremony



PUBLICITE


MondayJuly 02, 2012



Monday July 02, 2012 39

Chairpersons: Heather Zar (Cape Town, South Africa)Giovanni Rossi (Genoa, Italy)

1. Is this the End of the Road for Asthma as a Disease ?Fernando Martinez (Tucson, USA)

2. Understanding Asthma Genetics: The Road to Primary Prevention.Peter LeSouef (Perth, Australia)

3. How Should We Manage Asthma in Pre-schoolers - From Guidelines to Consensus.Andrew Bush (London, UK)

PLENARY SESSION2011 The Year in Review

08:30 am - 10:00 am Room A


Chairpersons: Alexander Tuazon (Manila, Philippines)Paul-Henri Torbey (Beirut, Lebanon)

1. Childhood Interstitial Lung Disease.Andrew Bush (London, UK)

2. Update on RSV Infections.Giovanni Rossi (Genoa, Italy)

3. Impact of Viral Bronchiolitis: Current Understanding and Treatment.Renato Stein (Porto Alegre, Brazil)

INFECTION, INFLAMMATION AND OTHER TOPICSEffusion and Empyema

Chairpersons: Matti Korppi (Kuopio, Finland)To be determined

1. Pro/Con Debate: Leave the Effusion Alone: Treatment of Parapneumonic Effusion. PRO: Eitan Kerem (Jerusalem, Israel)CON: Yakov Sivan (Tel-Aviv, Israel)

2. Pulmonary Empyema: The Australian Experience.Sarath Ranganathan (Melbourne, Australia)

PEARLSNew and Hot Topics in Respiratory Care

Chairmen: Peter LeSouef (Perth, Australia)Theodor Zimmermann (Erlangen, Germany)

1. Aerosol Therapy: New Drugs and New Devices.Sunalene Devadason (Perth, Australia)

2. New Modes of Non-invasive Ventilation NAVA and Beyond. Virginia Sison Kharasch (Boston, USA)

3. New Drugs and Devices for Airway Clearance.Bruce Rubin (Richmond, USA)

10:30 am - 12:00 pm Room B

10:30 am - 12:00 pm Room C

40 Monday July 02, 2012

OBSTRUCTIVE LUNG DISEASESLung and Airway Inflammation

10:30 am - 12:00 pm Room A


PAEDIATRIC RESPIRATORY REVIEWS (ELSEVIER) SATELLITE SYMPOSIUMConverting Research into Publications

12:00 pm - 01:30 pm Room A


Chairman: Dominic Fitzgerald (Sydney, Australia)

1. Introduction.Dominic Fitzgerald (Sydney, Australia)

2. How to Best Present Work at Meetings?Larry Lands (Montreal, Canada)

3. Getting Published.Bruce Rubin (Richmond, USA)

4. Working out where the ManuscriptsIs Best Suited.Andrew Bush (London, UK)

5. An Inreractive Session with a Panel to Answer Questions from the Floor.Chair/Panel


CLINICAL RADIOLOGICAL QUIZ DENOUEMENT

01:30 pm - 03:00 pm Room A

CLINICAL CASE PRESENTATIONS

01:30 pm - 03:00 pm Room B

Radiologist: Yaakov Bar Ziv (Jerusalem, Israel)

Clinician: Yakov Sivan (Tel-Aviv, Israel)

BRONCHOSCOPY QUIZ DENOUEMENT

03:00 pm - 04:30 pm Room A

Bronchoscopists: Robert Wood (Cincinnati, USA)

Clinician: Petr Pohunek (Prague, Czech Republic)

Chairs: Sarath Ranganathan (Melbourne, Australia)Teerachai Chantarojanasiri (Bangkok, Thailand)

Presenters:

1. Life Thratening Complications of Necrotizing Pneumonia: A Report of Two Cases.Nadir Demirel (Miami, USA)

2. Hypereosinophilic Syndrome Presenting with Pleural Effusion in Children: A Case Report.Huangji Cheng (Changchun, Chinal)

3. Recurrent Apnea Episodes as an Onset of a Primary Pulmonary Hypertension: A Case Report.Lina Jankauskaite (Kaunas, Lithuania)

4. Inflammatory Pseudotumor of Lung: An Unusual Mimicker of Intrathoracic Tuberculosis.Ankit Parakh (New Delhi, India)

5. Case of a Percystant Wheezer.Indu Khosla (Mumbai, India)

6. A child with Persistant Wheezing.Rujipat Samransamruajkit (Bangkok, Thailand)



CLOSING CEREMONY

04:30 pm - 05:00 pm Room A

• CLOSING CEREMONY

President's Address: Andrew Colin (Miami, USA)

Top 3 Poster Award Ceremony

Farewell Cocktail

05:00 pm - 05:30 pm

• Farewell Cocktail



ECO MEDICS Switzerland offers an innovative range of computerizedpulmonary diagnostic products ranging from neonatal to adultapplication. The main focus is the asthma management by exhaledNitric Oxide analysis and the detection of small airway disease (CF) bynitrogen washout FRC / LCI tests. The ANALYZER CLD 88sp is approvedfor routine clinical use of single and multiple breath exhaled NO,alveolar, nasal and offline FeNO measurements. The EXHALYZERD - pulmonary function testing device is designed for infant and adultapplication, especially the single and multiple breath nitrogenwashout FRC / LCI tests in pre-school to adult patients.

S. Karger AG of Basel, Switzerland, is a leading international publisherof books and journals in basic and medical sciences, covering bothresearch and clinical practice across many disciplines and providingauthors with a worldwide platform to present their findings. .

We are pleased to present our latest publications in RespiratoryMedicine at the Karger booth including the books PaediatricBronchoscopy and Paediatric Pulmonary Function Testing. Pick up asample copy of RESPIRATION, the official journal of the EuropeanAssociation for Bronchology and Interventional Pulmonology, orNEONATOLOGY which is devoted to fetal and neonatal research.

Founded in 1849, Pfizer is the world's premier biopharmaceuticalcompany applying science and our global resources to improve healthand well-being at every stage of life. We strive to set the standard forquality, safety and value in the discovery, development andmanufacturing of medicines for people and animals. Our diversifiedglobal health care portfolio includes human and animal biologic andsmall molecule medicines and vaccines, as well as nutritional productsand world's best-known consumer products. We also collaborate withhealth care providers, governments and local communities to supportand expand access to reliable, affordable health care around the world.

Today's MSD is a global healthcare leader working to help the worldbe well. MSD is a trade name of Merck & Co., Inc., with headquartersin Whitehouse Station, N.J., U.S.A. Through our prescription medicines,vaccines, biologic therapies, and consumer care and animal healthproducts, we work with customers and operate in more than 140countries to deliver innovative health solutions. We also demonstrateour commitment to increasing access to healthcare through far-reachingpolicies, programs and partnerships. For more information, visitwww.msd.com and connect with us on Twitter, Face book and You Tube.

GOLD SPONSOR

GOLD SPONSOR

SPONSORS



SPONSORS

Vertex creates new possibilities in medicine. Our team discovers,develops and commercializes innovative therapies so people withserious diseases can lead better lives.

Vertex scientists and our collaborators are working on new medicinesto cure or significantly advance the treatment of hepatitis C, cysticfibrosis, rheumatoid arthritis, epilepsy and other life-threateningdiseases.

Founded more than 20 years ago in Cambridge, MA, we now haveongoing worldwide research programs and sites in the U.S., U.K. andCanada. Today, Vertex has more than 2,000 employees around theworld, and Sciencemagazine named Vertex number one on its 2011 listof Top Employers in the life sciences.

PROTECSOM is a French medical device designer in asthma, allergy andpulmonary diseases.

The aim of ProtecSom products is improving compliance, patient’squality of life and easiness to caregivers.

Combihaler®, a new spacer allowing use of both a pMDI and anebulizer in a mechanical ventilation circuit will be presented for thefirst time. It saves up to 50% of the nebulized drug.

Itinhaler®, a flexible valved holding chamber made of silicone isdesigned to improve compliance of teenagers.

Tips-Haler®, thanks to Isobreath® system, is specially designed toprovide a deeper deposition of fine particles in low stages of the lung.

GlaxoSmithKline - GSK Thailand has a long history in the Thaipharmaceutical market and is a well-known and well-respected leaderof the industry. GSK is actively involved in community partnerships andis a key contributor to public and non-profit organizations. Theompany's initiative supports GSK Global policy's Access to Medicineframework, which aims to increase access to quality, innovativemedicines and vaccines for all people, including those at the lower endof the economic spectrum.

Key Products in Thailand:• Pharmaceutical products: respiratory and allergy therapeutics,

antibiotics, anti-viral therapeutics, cancer therapeutics, neuropathytreatments

• Vaccines for every age

Through our core values and mission, GSK will continue our effort toenable people to do more, feel better and live longer.



SPONSORS


The Boehringer Ingelheim group is one of the world’s 20 leadingpharmaceutical companies. Headquartered in Ingelheim, Germany, itoperates globally with 145 affiliates and more than 42,000 employees.Since it was founded in 1885, the family-owned company has beencommitted to researching, developing, manufacturing and marketingnovel products of high therapeutic value for human and veterinarymedicine.

As a cenral element of its culture, Boehringer Ingelheim pledges to actsocially responsible. Involvement in social projects, caring foremployees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutualcooperation and respect, as well as environmental protection andsustainability are intrinsic factors in all of Boehringer Ingelheim’sendeavors.

In 2010, Boehringer Ingelheim posted net sales of about 12.6 billioneuro while spending almost 24% of net sales in its largest businesssegment Prescription Medicines on research and development.

For more information please visit www.boehringer-ingelheim.com

Sanofi is a research-based global healthcare leader, with a strongpresence in Pakistan.

Sanofi Pakistan has a proud and rich heritage of pharmaceuticalresearch and development. The guiding principle of Sanofi’s businessactivities has always been to discover and develop innovative, effectiveand well-tolerated treatments and make them available to doctorsand their patients.

The manufacturing facilities are among the most modern andenvironmentally friendly facilities in the country. The rich productportfolio includes life-saving drugs, several of which are leaders intheir respective classes.

At Sanofi, we believe when the world has its health, it will have everything.



27, rue Masséna 06000 Nice, France

e-mail: [email protected]

Phone: + 33 (0) 497 038 597

Fax: + 33 (0) 497 038 598

Organizers:


Documents

Mise en page 1 - Spitta · 4 CENTRAL ORGANIZING COMMITTEE Andrew Colin (Miami, USA) President Eitan Kerem (Jerusalem, Israel) Past President Gary Wong (Hong-Kong, China) Co-Chair,